维普中文期刊产品整合服务
9篇 您的检索式:作者名="Rainer Sauerborn"
    题名 作者 年代 出处 被引量
1One hundred and eighteen years of the German health insurance system: are there any lessons for middle- and low-income countries?显示文摘Till B?rnighausen Rainer Sauerborn 2002Social Science & Medicine2002,,10:2
2Provider payment methods and health worker motivation in community-based health insurance: A mixed-methods study显示文摘Paul Jacob Robyn Till B?rnighausen Aurélia Souares Adama Traoré Brice Bicaba Ali Sié Rainer Sauerborn 2014Social Science & Medicine2014,,:1
3Health economic evaluation of moist wound care in chronic cutaneous leishmaniasis ulcers in Afghanistan显示文摘Background:The present health economic evaluation in Afghanistan aims to support public health decision makers and health care managers to allocate resources efficiently to appropriate treatments for cutaneous leishmaniasis(CL)elicited by Leishmania tropica or Leishmania major.Methods:A decision tree was used to analyse the cost and the effectiveness of two wound care regimens versus intra-lesional antimony in CL patients in Afghanistan.Costs were collected from a societal perspective.Effectiveness was measured in wound free days.The incremental cost-effectiveness ratio(ICER)and incremental net monetary benefit(NMB)were calculated.The model was parameterized with baseline parameters,sensitivity ranges,and parameter distributions.Finally,the model was simulated and results were evaluated with deterministic and probability sensitivity analyses.Final outcomes were the efficiency of the regimens and a budget impact analysis in the context of Afghanistan.Results:Average costs per patients were US$11(SE=0.016)(Group I:Intra-dermal Sodium Stibogluconate[IL SSG]),US$16(SE=7.58)(Group II:Electro-thermo-debridement[ETD]+Moist wound treatment[MWT])and US$25(SE=0.48)(Group III:MWT)in patients with a single chronic CL ulcer.From a societal perspective the budget impact analysis shows that the regimens’drug costs are lower than indirect disease cost.Average effectiveness in wound free days are 177(SE=0.36)in Group II,147(SE=0.33)in Group III,and 129(SE=0.27)in Group I.The ICER of Group II versus Group I was US$0.09 and Group III versus Group I US$0.77,which is very costeffective with a willingness-to-pay threshold of US$2 per wound free day.Within a Monte-Carlo probabilistic sensitivity analysis Group II was cost-effective in 80%of the cases starting at a willingness-to-pay of 80 cent per wound free day.Conclusions:Group II provided the most cost-effective treatment.The non-treatment alternative is not an option in the management of chronic CL ulcers.MWT of Group III should at least be practiced.The costeffectiveness of Group III depends on the number of dressings necessary until complete wound closure.Hans-Christian Stahl Faridullah Ahmadi Sami Mohammad Nahzat Heng-Jin Dong Kurt-Wilhelm Stahl Rainer Sauerborn 2018Infectious Diseases of Poverty2018,7,1:1
4Household decision-making on ehild health care in developing countries: the case of Nepal 显示文摘Subhash Pokhrel Rainer Sauerborn 2004Health Policy and Planning2004,19,4:1
5One hundred and eighteen years of the German health insurance system: are there any lessons for middle-and low-income countries 显示文摘Till Barnighausen and Rainer Sauerborn 2002Social Science & Medicine 2002 542002,,:1
6One hundred and eighteen years of the German health insurance system:are there any lessons for middle and Low income countries显示文摘Till Barnighausen Rainer Sauerborn 0,,:1
7Potential Distribution of Dengue Fever Under Scenarios of Climate Change and Economic Development显示文摘Christofer ?str?m Joacim Rockl?v Simon Hales Andreas Béguin Valerie Louis Rainer Sauerborn 2013EcoHealth2013,,4:1
8德国健康保险的逐步发展机制显示文摘德国健康保险发展从建立之初到现在都具有逐步发展的特征,主要表现在疾病基金会组织有关的法律不断完善、保险覆盖人口的不断增加、抗风险能力的扩大、服务包的改变等方面。从跨区域强制性保险确立前后的两个时期介绍、分析德国健康保险的逐步发展特征。Till Baernighausen Rainer Sauerborn 张新平 崔斌 孙碧玉 徐海锋 2000中国社会医学杂志2000,17,1:0
9德国门诊预算控制的历史性回顾及其特征显示文摘运用历史研究方法对德国门诊费用控制的变迁进行分析 ,介绍并分析了德国不同时期门诊费用变化、保险对门诊医生费用支付方式和门诊费用控制措施的变化 。TillBaernighausen Rainer Sauerborn 崔斌 孙碧玉 徐海锋 张新平 2000中国社会医学杂志2000,17,4:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费